Clarence J. Peters mainly focuses on Virology, Virus, Ebola virus, Immunology and Outbreak. Clarence J. Peters combines subjects such as Antibody, Serology and Antigen with his study of Virology. His Viral disease and Viral replication study, which is part of a larger body of work in Virus, is frequently linked to Filoviridae, bridging the gap between disciplines.
His work on Ebola Hemorrhagic Fever as part of general Ebola virus research is frequently linked to Mononegavirales, thereby connecting diverse disciplines of science. His work on Alpha interferon, Interferon alfa, Vaccination and Immunity as part of general Immunology research is frequently linked to Coronavirus, bridging the gap between disciplines. His Outbreak research incorporates elements of Vegetation, Hantavirus pulmonary syndrome, Hantavirus and Satellite imagery.
Clarence J. Peters mostly deals with Virology, Virus, Immunology, Hantavirus pulmonary syndrome and Hantavirus. His research in Virology intersects with topics in Antibody and Serology. In his study, Arenaviridae and Lassa fever is strongly linked to Arenavirus, which falls under the umbrella field of Virus.
In general Hantavirus pulmonary syndrome, his work in Andes virus is often linked to Reassortment linking many areas of study. His Hantavirus research includes elements of Disease reservoir and Peromyscus. His work on Ebola Hemorrhagic Fever and Ebolavirus as part of general Ebola virus study is frequently linked to Mononegavirales and Filoviridae, bridging the gap between disciplines.
His primary scientific interests are in Virology, Virus, Immunology, Viral replication and Rift Valley fever. His Virology study integrates concerns from other disciplines, such as Arenavirus, Sigmodontinae and Junin virus. His work carried out in the field of Virus brings together such families of science as Disease reservoir, Pathogenesis and Hamster.
His study in the fields of Vaccination, Viral disease and Viral Vaccine under the domain of Immunology overlaps with other disciplines such as Coronavirus. His Rift Valley fever study incorporates themes from Veterinary medicine, Phlebovirus, Cartography and Archaeology. His studies examine the connections between Outbreak and genetics, as well as such issues in Disease, with regards to Cross-sectional study.
Clarence J. Peters focuses on Virology, Immunology, Coronavirus, Innate immune system and Interferon. His work on Viral replication as part of his general Virology study is frequently connected to Genealogy, thereby bridging the divide between different branches of science. His Immunology study is mostly concerned with Virus, Immune system, Proinflammatory cytokine and Interferon regulatory factors.
His Virus research is multidisciplinary, incorporating perspectives in Alum adjuvant and Immunopathology. His Innate immune system study combines topics in areas such as Cell culture, Respiratory epithelium, Gene and Immunity. The study incorporates disciplines such as Inflammation and RNA virus in addition to Interferon.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Nipah Virus: A Recently Emergent Deadly Paramyxovirus
K. B. Chua;W. J. Bellini;P. A. Rota;B. H. Harcourt.
Science (2000)
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.
Anthony Sanchez;Sam G. Trappier;Brian W. J. Mahy;Clarence J. Peters.
Proceedings of the National Academy of Sciences of the United States of America (1996)
Clinical virology of Ebola hemorrhagic fever (EHF): Virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995
T. G. Ksiazek;P. E. Rollin;A. J. Williams;D. S. Bressler.
The Journal of Infectious Diseases (1999)
Markedly elevated levels of interferon (IFN)-γ, IFN-α, interleukin (IL)-2, IL-10, and tumor necrosis factor-α associated with fatal Ebola virus infection
Francois Villinger;Pierre E. Rollin;Sukhdev S. Brar;Nathaniel F. Chikkala.
The Journal of Infectious Diseases (1999)
Evaluation of Immune Globulin and Recombinant Interferon-α2b for Treatment of Experimental Ebola Virus Infections
Peter B. Jahrling;Peter B. Jahrling;Peter B. Jahrling;Thomas Geisbert;Thomas Geisbert;J. B. Geisbert;J. B. Geisbert;J. R. Swearengen;J. R. Swearengen.
The Journal of Infectious Diseases (1999)
An Outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98
Christopher W. Woods;Adam M. Karpati;Thomas Grein;Noel McCarthy.
Emerging Infectious Diseases (2002)
Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection
Toshiaki Maruyama;Luis L. Rodriguez;Peter B. Jahrling;Anthony Sanchez.
Journal of Virology (1999)
Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome.
C. J. Peters;Gary L. Simpson;H. Levy.
Annual Review of Medicine (1999)
ELISA for the Detection of Antibodies to Ebola Viruses
Thomas G. Ksiazek;Thomas G. Ksiazek;Cynthia P. West;Pierre E. Rollin;Pierre E. Rollin;Peter B. Jahrling.
The Journal of Infectious Diseases (1999)
Syndromic Surveillance and Bioterrorism-related Epidemics
James W. Buehler;Ruth L. Berkelman;David M. Hartley;Clarence J. Peters.
Emerging Infectious Diseases (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
The University of Texas Medical Branch at Galveston
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
University of Nebraska Medical Center
Centers for Disease Control and Prevention
University of Perpignan
Yale University
Emory University
The University of Texas Medical Branch at Galveston
Centers for Disease Control and Prevention